Why the study?
The study was conducted to investigate the biochemical and histopathological effects of metyrosine on ischemia-reperfusion-induced ovarian injury in rats.
Does metyrosine reduce oxidative and pro-inflammatory damage in ischemia-reperfusion-induced ovarian injury in rats?
Population
Rats
Comparison
Ovarian I/R plus metyrosine vs ovarian I/R alone vs sham operation
Design
Animal experimental study
Key result
Metyrosine administration prior to ischemia-reperfusion reduced ovarian oxidative and pro-inflammatory damage, lowering MDA and COX-2 while increasing tGSH, SOD, and COX-1 levels in rats.
Authors
Loading...
Metyrosine attenuated ovarian IR injury in rats; hypothesis-generating and should not yet change practice.
Does metyrosine reduce oxidative and pro-inflammatory damage in ischemia-reperfusion-induced ovarian injury in rats?
Metyrosine inhibits oxidative and pro-inflammatory damage associated with ovarian ischemia-reperfusion injury in a rat model.
Yapça et al. (2023) studied Ischemia-reperfusion (I/R) induced ovarian injury. Metyrosine vs. Distilled water (OIR group) and sham operation was evaluated on Biochemical markers (MDA, COX-2, tGSH, SOD, COX-1) and histopathological injury. Metyrosine administration prior to ischemia-reperfusion reduced ovarian oxidative and pro-inflammatory damage, lowering MDA and COX-2 while increasing tGSH, SOD, and COX-1 levels in rats.